Back to 
CITADEL ADVISORS LLC
CITADEL ADVISORS LLC
NSRX1 quarters
Position history for CITADEL ADVISORS LLC's holdings in NASUS PHARMA LTD
Yes. Citadel Advisors holds 22,004 shares of NSRX (Nasus Pharma), worth $77,014, as of its Q2 2026 13F filing. It opened the position in Q2 2026.
Current Value
$77,014
Current Shares
22,004
Total Value Change
$0
Total Shares Change
0
Quarter-by-Quarter History
Other major holders of NSRX: BALYASNY ASSET MANAGEMENT L.P., Hudson Bay Capital Management LP, HRT FINANCIAL LP